Document is current
Any future updates will be listed below
-
Authors
Beghetti, Maurice
Ivy, Dunbar
Scott, Nicola
Machlitt-Northen, Sandra
Lukas, Mary Ann
-
Funding
Funding for this research was provided by:
GlaxoSmithKline
- License Information
-
More Information
Article History
Received: 3 February 2023
Revised: 7 February 2023
Accepted: 13 February 2023
First Online: 27 February 2023
Declarations
:
: Not applicable.
: For Dunbar Ivy, the University of Colorado contracts with GSK, Actelion, Eli Lilly, and United Therapeutics to be a consultant. Maurice Beghetti reports remunerations for lectures and/or consultancy from Actelion, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline (GSK), Merck Sharp & Dohme, and Pfizer and unrestricted research grants from Actelion and Bayer. Mary Ann Lukas, Nicola Scott, and Sandra Machlitt-Northen are employees of GSK and hold shareholder status in the company.
